首页> Frontiers in endocrinology> Selection for CD26- and CD49A+ Cells From Pluripotent Stem Cells-Derived Islet-Like Clusters Improves Therapeutic Activity in Diabetic Mice.

Selection for CD26- and CD49A+ Cells From Pluripotent Stem Cells-Derived Islet-Like Clusters Improves Therapeutic Activity in Diabetic Mice.

导出 LinkOut

翻译打印收藏纠错

第一作者： Kfir,Molakandov

第一单位： Kadimastem Ltd., Weizmann Science Park, Ness Ziona, Israel.

作者： Kfir,Molakandov ^[1] ; Denise A,Berti ^[1] ; Avital,Beck ^[1] ; Ofer,Elhanani ^[2] ; Michael D,Walker ^[2] ; Yoav,Soen ^[2] ; Karina,Yavriyants ^[1] ; Michal,Zimerman ^[1] ; Ella,Volman ^[1] ; Itzik,Toledo ^[1] ; Anna,Erukhimovich ^[1] ; Alon M,Levy ^[1] ; Arik,Hasson ^[1] ; Joseph,Itskovitz-Eldor ^[1] ; Judith,Chebath ^[1] ; Michel,Revel ^[3]

作者单位： Kadimastem Ltd., Weizmann Science Park, Ness Ziona, Israel. ^[1] Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel. ^[2] Kadimastem Ltd., Weizmann Science Park, Ness Ziona, Israel.;Department of Molecular Genetics (emeritus), Weizmann Institute of Science, Rehovot, Israel. ^[3]

关键词 DPP4 (CD26)STZ-treated C57BL/6 mice diabetes models alginate encapsulation functional cell capture screening human ESC-derived insulin producing cells integrin alpha1 (CD49A)islet-like clusters (ILC)